Abstract:

This is the review of the article “Drinking water composition and Incidence of Urinars calculus.’ It is study for pathophysiology of urinary calculus due to electrolytes in water and whether these electrolytes contribute to water quality besides hardness causing the calculus formation.

References:

1.      Alapont Perez FM, Galvez Calderon J, Varea Herrero J, Colome Borros G, Olaso Oltra A, Sanchez Bisono JR. [Epidemiology of urinary lithiasis]. Actas Urol Esp. 2001;25:341-9. Spanish.

2.      Barker DJ, Donnan SP. Regional variations in the incidence of upper urinary tract stones in England and Wales. Br Med J. 1978;1:67-70.

3.      Basiri A, Shakhssalim N, Khoshdel AR, Naghavi M. Regional and seasonal variation in the incidence of urolithiasis in Iran: a place for obsession in case finding and statistical approach. Urol Res. 2009.

4.      Bellizzi V, De Nicola L, Minutolo R, et al. Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis. Nephron. 1999;81 Suppl 1:66-70.

5.      Caudarella R, Rizzoli E, Buffa A, Bottura A, Stefoni S. Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol. 1998;159:658-63.

6.      Churchill D, Bryant D, Fodor G, Gault MH. Drinking water hardness and urolithiasis. Ann Intern Med. 1978;88:513-4.

7.      Coen G, Sardella D, Barbera G, et al. Urinary composition and lithogenic risk in normal subjects following oligomineral versus bicarbonate-alkaline high calcium mineral water intake. Urol Int. 2001;67:49-53.

8.      Desmars JF, Tawashi R. Dissolution and growth of calcium oxalate monohydrate. I. Effect of magnesium and pH. Biochim Biophys Acta. 1973;313:256-67.

9.      Ettinger B, Pak CY, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158:2069-73.

10.  Gershoff SN, Prien EL. Effect of daily MgO and vitamin B6 administration to patients with recurring calcium oxalate kidney stones. Am J Clin Nutr. 1967;20:393-9.

11.  Johansson G, Backman U, Danielson BG, Fellstrom B, Ljunghall S, Wikstrom B. Biochemical and clinical effects of the prophylactic treatment of renal calcium stones with magnesium hydroxide. J Urol. 1980;124:770-4.

12.  Khan SR, Shevock PN, Hackett RL. Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis. J Urol. 1993;149:412-6.

13.  Kohri K, Garside J, Blacklock NJ. The role of magnesium in calcium oxalate urolithiasis. Br J Urol. 1988;61:107-15.

14.  Kohri K, Kodama M, Ishikawa Y, et al. Magnesium-to- calcium ratio in tap water, and its relationship to geological features and the incidence of calcium-containing urinary stones. J Urol. 1989;142:1272-5.

15.  Kohri K, Ishikawa Y, Iguchi M, Kurita T, Okada Y, Yoshida O. Relationship between the incidence infection stones and the magnesium-calcium ratio of tap water. Urol Res. 1993;21:269-72.

16.  Li MK, Blacklock NJ, Garside J. Effects of magnesium on calcium oxalate crystallization. J Urol. 1985;133:123-5.

17.  Meyer JL, Smith LH. Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol. 1975;13:36-9.

18.  Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13 Suppl 3:S45-50.

19.  Reungjui S, Prasongwatana V, Premgamone A, Tosukhowong P, Jirakulsomchok S, Sriboonlue P. Magnesium status of patients with renal stones and its effect on urinary citrate excretion. BJU Int. 2002;90:635-9.

20.  Schwartz BF, Bruce J, Leslie S, Stoller ML. Rethinking the role of urinary magnesium in calcium urolithiasis. J Endourol. 2001;15:233-5.

21.  Sierakowski R, Finlayson B, Landes R. Stone incidence as related to water hardness in different geographical regions of the United States. Urol Res. 1979;7:157-60.

22.  Shuster J, Finlayson B, Scheaffer R, Sierakowski R, Zoltek J, Dzegede S. Water hardness and urinary stone disease. J Urol. 1982;128:422-5.

23.  Singh PP, Kiran R. Are we overstressing water quality in urinary stone disease? Int Urol Nephrol. 1993;25:29-36.

24.  Sowers MR, Jannausch M, Wood C, Pope SK, Lachance LL, Peterson B. Prevalence of renal stones in a population-based study with dietary calcium, oxalate, and medication exposures. Am J Epidemiol. 1998;147:914-20.

25.  Wickham JEA, Buck AC. Renal tract stone: metabolic basis and clinical practice. Edinburgh: Churchill Livingstone; 1990.

26.  Water Quality Association [homepage on the internet]. Centralized “water softening” — know the facts [cited 26 Jul, 2008]. Available from: http://www.wqa.org/sitelogic.cfm?ID=1052.

27.  Zerwekh JE, Odvina CV, Wuermser LA, Pak CY. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. J Urol. 2007;177: 2179-84.